Meisoindigo for the treatment of chronic myelogenous leukaemia.
Xiao
Z
Z
Qian
L
L
Liu
B
B
Hao
Y
Y
D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies
D004365:Drugs, Chinese Herbal; D007211:Indoles; D019384:Nucleic Acid Synthesis Inhibitors; C047330:N-methylisoindigotin; D006918:Hydroxyurea